Developer of a complementary-regulating therapy platform designed to mitigate harmful immune responses in extracorporeal medical procedures. The company offers a novel priming protein that coats dialy...

Healthcare
Edinburgh, United Kingdom
Founded 2018
5 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$19M
Last Round
N/A

Get the full picture

Create a free account to unlock Invizius's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required